enGene Therapeutics Inc.

ENGN·NasdaqCM
Compare
1.7000−0.0300 (−1.73%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.7300
Open1.7300
Day range1.69001.7400
52-week range1.400012.2500
Off day high−2.30%
Off 52-week high−86.12%
Volume462.72K
Avg. volume (3M)736.63K
Market cap113.93M
EPS (TTM)-2.07
Forward P/E-1.17
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding67.02M
Short interest—
Earnings dateSep 8, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
ENGN ONCY TRDA CADL CSBR PLYX
Market cap 113.93M 62.06M 214.15M 748.35M 68.94M 100.19M
P/E (TTM) — — — — — —
Forward P/E -1.2 -2.4 -1.8 -15.6 49.5 —
Price/book 0.5 -9.7 0.8 5.9 17.7 9.2
Dividend yield — — — — — —
1-year change −79.13% −52.14% −2.41% +53.63% −25.65% −94.29%
Today −1.73% −15.03% −3.00% −1.61% −0.54% +0.50%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ENGN news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.